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 22 
Abstract 23 
The present study introduces a novel triple-phase (liquids, solids and gases) approach, which 24 
employed uniformly labelled [U-13C] polydextrose (PDX) for the selective profiling of 25 
metabolites generated from dietary fiber fermentation in an in vitro colon simulator using human 26 
fecal inocula. Employing 13C NMR spectroscopy, [U-13C] PDX metabolism was observed from 27 
colonic digest samples. The major 13C-labelled metabolites generated were acetate, butyrate, 28 
propionate, and valerate. In addition to these short-chain fatty acids (SCFAs), 13C-labelled 29 
lactate, formate, succinate, and ethanol were detected in the colon simulator samples. Metabolite 30 
formation and PDX substrate degradation were examined comprehensively over time (24 and 48 31 
hours). Correlation analysis between 13C NMR spectra and gas production confirmed the 32 
anaerobic fermentation of PDX to SCFAs. In addition, 16S rRNA gene analysis showed that the 33 
level of Erysipelotrichaceae was influenced by PDX supplementation and Erysipelotrichaceae 34 
level were statistically correlated with SCFA’s formation.  Overall, our study demonstrates a 35 
novel approach to link substrate fermentation and microbial function directly in a simulated 36 
colonic environment.        37 
 38 
Keywords. Gut microbiome, Dietary fiber, 13C-labelled metabolites, 13C NMR    39 
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Introduction 40 
The human gut harbours a complex microbial ecosystem, and the gut microbial activity has been 41 
recognized as a pivotal regulator of the host metabolism.1-4 Recent evidence revealing that gut 42 
microbial activity can be influenced by dietary fiber (i.e. non-digestible food ingredients), has led 43 
to an increased demand for evaluation of the specific functions of these ingredients in the gut.5-7 44 
Polydextrose (PDX), which is used as functional ingredient in a variety of foods, is a highly 45 
branched and complex polymer of glucose. PDX is a soluble fiber produced by thermal 46 
condensation of glucose and possesses prebiotic effects as a food ingredient.8-9 An understanding 47 
of the microbial composition and metabolism is fundamental to evaluate the effects of dietary 48 
fibers in the gut.  In addition, evaluating the selective microbial products formed from the 49 
substrate is key to directly linking gut microbial activity and health benefit of any particular 50 
dietary fiber. Stable isotope labelling provides an excellent approach for tracking the conversion 51 
of the substrate and identifying resultant metabolic products, thus allowing a rapid and 52 
comprehensive profiling of selective microbial activity.10 An approach using uniformly labelled 53 
[U-13C] substrate also offers a robust method to elucidate the metabolic pathways involved in the 54 
microbial metabolism. In fact, previous studies based on stable isotope labelling have shown the 55 
usefulness of [U-13C] approaches. For instance, de Graaf et al. introduced 13C enrichment as an 56 
approach to evaluate the kinetics of 13C-labelled glucose fermentation in an in vitro colon 57 
model.11-13    58 
 59 
To characterize the metabolic process of dietary fiber catabolism, an in vitro colon simulator 60 
offers the advantage of enabling dynamic sampling and implying substantially less ethical issues 61 
compared to an in vivo study. On that account, an in vitro colon model could be a robust 62 
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approach to profile the complete set of 13C-labelled metabolites produced during the microbial 63 
fermentation processes. Nuclear magnetic resonance (NMR) or mass spectrometry (MS) is often 64 
used to measure the isotopically labelled metabolites in biological samples. An NMR-based 65 
approach can directly detect an isotopic label in the molecule and distinguish different 66 
isotopomers, whereas MS-based techniques requires complicated protocols with different 67 
ionizations and derivatization steps to obtain information on the isotopomer.11 Nevertheless, both 68 
analytical platforms provide complementary information. In this study, we employed a 69 
combination of liquid and solid state NMR to characterize the fate of uniformly labelled [U-13C] 70 
PDX catabolism by gut microbiota in a four-stage in vitro colon simulator model. 71 
Concomitantly, gas chromatography (GC) coupled with MS was used to monitor the gas 72 
generated during PDX catabolism. In addition, 16S rRNA gene amplicon sequencing was 73 
performed to identify and compare the microbial composition within the given sample sets. 74 
Overall, the aim was to measure the selective metabolic and microbial changes occurring in the 75 
colon simulator using uniformly labelled [U-13C] PDX as a substrate for gut microbes.  76 
 77 
 78 
 79 
 80 
 81 
 82 
 83 
 84 
  85 
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Material and methods  86 
Human colon simulator   87 
The in vitro simulator used for the study models the human large intestine (Figure 1A). This 88 
anaerobic in vitro colon model has been used to investigate the fermentation, and function of 89 
prebiotic and probiotic ingredients.6, 14-15 Mäkivuokko et al. have previously described the 90 
technical specification of this in vitro model.16 Briefly, the simulator used for the study consists 91 
of eight separate units, each containing four semi-continuously connected glass vessels. The 92 
vessels in each unit (V1 to V4) model the ascending (V1), transverse (V2), descending (V3) and 93 
sigmoidal (V4) parts of the human colon, respectively. In the initial phase of the simulation, each 94 
unit is inoculated with pre-incubated fecal inoculum obtained from a fresh human fecal sample, 95 
which forms the microbiota of the colonic model. These fecal inoculums are prepared with three 96 
parts (w/v) of anaerobic simulator medium, incubated anaerobically for 24 hours at 37 o C 97 
(details in16). In this study, three healthy Finnish volunteers provided the fecal samples for 98 
inoculum. According to Finnish law, no ethical approval was required, since there has not been 99 
any interference with a person’s physical or mental integrity. During simulation, the fecal 100 
inoculum from one volunteer was used, and the system was fed with a synthetic ileal medium in 101 
three-hour cycles to simulated colon model for 24 or 48 hours, during which transition of 102 
fermented fluids and microbes and feeding of fresh medium occurred.  As test substance, 2% 103 
PDX with natural isotope abundance (Litesse Ultra; Danisco UK, Redhill, U.K.) or 2% [U-13C]-104 
PDX (Danisco Denmark, Grindsted, Denmark) was added to the synthetic ileal medium used as 105 
feeding solution. The syntetic ileal medium without addition of any PDX was used as a control 106 
(CTRL). The synthetic ileal medium was used as a control (CTRL). The simulations were 107 
performed at DuPont, Nutrition and Health, Kantvik, Finland. To track the microbial activity 108 
Page 5 of 37
ACS Paragon Plus Environment
Journal of Proteome Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
6 
 
over time, the microbial slurry and gas were collected from all vessels (V1-V4) after 24 and 48 109 
hours of simulation. In total, 72 (3donors*4vessels (V1-V4)*2time points (24 and 48 hours)*3without PDX (CTRL)/2% 110 
PDX/ 2% [U-13C] - PDX) samples were collected from the in vitro colon simulator and stored at -80 
oC 111 
prior to analysis. 112 
 113 
Preparation of simulated fecal water samples 114 
The collected fecal slurry samples from the simulator were homogenized by vortex mixing for 1 115 
min, and then centrifuged at 5,000 g for 10 minutes at 4 °C (Eppendorf 5471, USA). The 116 
supernatants were removed carefully and subsequently lyophilized. The sample pre-treatment 117 
(adjusting the pH ≥  7) before lyophilisation was carried out as recommended by Jacobs et al.17 118 
The remaining pellets were stored at -80°C for solid-state NMR analysis. Lyophilized fecal 119 
samples were reconstituted in D2O and the samples were homogenized by vortex mixing and 120 
then centrifuged at 10,000 g for 10 minutes at 4 °C. 121 
 122 
Spectroscopic analyses 123 
Liquid-state NMR 124 
A volume of 600 µL supernatant containing 0.025 mg/mL 3-trimethylsilyl propionic acid-d4 125 
sodium salt (TSP) as reference compound was transferred to a 5 mm NMR tube. One-126 
dimensional 13C NMR experiments were acquired using a Bruker Avance III 800 MHz 127 
spectrometer equipped with a 5-mm 1H observe TCI cryoprobe (Bruker Biospin, Rheinstetten, 128 
Germany) at 25°C. A standard pulse sequence using power-gated decoupling and 30° flip angle 129 
was used (zgpg30). Acquisition parameters for the spectra were 128 scans, a spectral width of 130 
48077 Hz collected into 64 K data points, an acquisition time of 0.68 s and an inter-scan 131 
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relaxation delay of 5 s. The Free Induction Decay (FID) obtained was multiplied by 1 Hz of 132 
exponential line broadening before Fourier transformation. The spectra were referenced to TSP 133 
(chemical shift defined at 0 ppm), phased, and baseline corrected in Topspin 3.0 software. 134 
Assignments of 13C NMR signals were carried out according to the Human Metabolome 135 
Database.18 In addition, an HSQC experiment was acquired with a spectral width of 11961 Hz in 136 
the 1H dimension and 33276 Hz in the 13C dimension, a matrix with a size of 1024×128 complex 137 
data points, 2 transients per increment and a relaxation delay of 1.5 s. Besides 1D carbon spectra, 138 
13C positional enrichment were confirmed by 1H NMR spectroscopy (13C decoupled and 13C 139 
coupled spectra) using a Bruker Avance III 500 MHz spectrometer equipped with a 5 mm triple 140 
resonance (TXI) probe at 25°C (experiment details in Supporting information (SI)).   141 
Solid-state NMR  142 
The pellets obtained from the in vitro colon fecal slurry were analyzed using cross-polarization 143 
magic-angle spinning (CP MAS) NMR. Lyophilized pellet samples (mean sample weight: 29.38 144 
mg) were powdered and packed in 4-mm diameter zirconium rotors (Bruker Biospin, 145 
Rheinstetten, Germany). 13C CP MAS NMR spectra were acquired on a Bruker Avance III 600 146 
MHz spectrometer equipped with a 1H/13C CP MAS probe with gradient aligned along the magic 147 
angle. For acquisition of 13C CP MAS NMR spectra, a contact time of 0.5 ms, a proton field of 148 
approximately 45 kHz during CP and data acquisition, a relaxation delay of 2 s and a spinning 149 
speed of 14 kHz were employed. The FID was multiplied by 50 Hz of exponential line 150 
broadening before Fourier transformation. The spectra were phased, and baseline corrected using 151 
Bruker Topspin 3.0 software.    152 
 LC-MS analysis 153 
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The HP-LC was operated at a flow rate of 12 uL/min, and the mobile phase consisted of solution 154 
A (0.1% HCO2H in water) and solution B (0.1% HCO2H in ACN). For all analyses, 1 uL of 155 
calibrant (sodium formate) and sample were used. The samples were separated by an eclipse plus 156 
phenyl C18 column (Agilent Technologies, Waldbronn, Germany), using the following gradient: 157 
2% B for 4 min, linear gradient of 2-60% B in 10 min, 60-90% B in 3 min, 90% B for 2 min, 90-158 
2% B in 1 min, and 2% B for 10 min.  MS was operated in both negative and positive ion mode. 159 
The mass range was set from 40 to 800 m/z, and data were acquired in profile mode at a 160 
frequency of 1 Hz with active focus mode off. The raw data were automatically calibrated using 161 
the sodium formate cluster signals and required m/z values were integrated in the data analysis 162 
software package Compass HyStar (Bruker Daltonics, Bremen, Germany).  163 
 164 
CO2 analysis by GC-MS 165 
CO2 analysis was performed using an Agilent Technologies 6890N/5975C GC-MS system. A 166 
total of 250 µL sample was injected (split ratio 1:150) using a 2.5 mL heated syringe (50 °C), 167 
into a 50 m (L) x 0.25 mm (ID) x 0.25 µm (df) FFAP column (Quadrex, Bethany, CT 06524 168 
USA ), kept at 30 °C. Helium was used as carrier gas at 1 mL/min. The sampling needle was 169 
flushed with He between sample injections to avoid interference from air and from the previous 170 
sample. The MS was used in full scan mode (scan range 10 – 100 amu) with electron ionization 171 
(70 eV). The selected ions were m/z=44 for 12CO2 and m/z=45 for 
13CO2 with retention time of 172 
161 s. Argon (Ar) with m/z=40 was used as a reference gas for relative quantification of the 173 
gases.  174 
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Metabolite data analysis 175 
1H NMR spectra were imported into Matlab R2014b (The Mathworks, Inc., USA) and the 176 
misalignments of the spectra were corrected using the icoshift algorithm based on the 177 
correlational shifting of spectral intervals.19 The spectra were mean centered and pareto-scaled 178 
before principal component analysis (PCA). PCA was performed using the PLS Toolbox 179 
(Eigenvector Research, USA) in MATLAB R2014b. Relative quantification of selected 13C 180 
resonances were performed by integration of peak areas in MATLAB R2014b. Spearman 181 
correlation coefficient between the integrals of these metabolites was calculated using the 182 
statistical toolbox in Matlab R2014b. The results were illustrated by heat maps using MATLAB 183 
R2014b 184 
 185 
Extraction and quantification of bacterial DNA 186 
The DNA from the simulation samples was extracted and purified with an automated 187 
MagMAX™ Sample Preparation System (Life Technologies, Halle, Belgium), using the 188 
MagMAX™ Nucleic Acid Isolation Kit. The amount of extracted DNA was determined by a 189 
Qubit® dsDNA HS Assay Kit (Thermo Fisher Scientific, Vantaa, Finland). Concurrently, non-190 
template negative controls were processed to detect possible contamination. 191 
16S rRNA gene amplicon sequencing and microbiome data analysis 192 
The V4 region of the 16S rRNA gene communities was amplified using a PCR workflow as 193 
previously described.20 Purified amplicons were pooled and sequenced using 2 x 250 base pair 194 
(bp) Paired-End Illumina MiSeq (Pioneer, Johnston, IA). Resulting sequencing data were 195 
analyzed using the Quantitative Insights into Microbial Ecology (QIIME, v. 1.9.1) pipeline.21 196 
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Sequencing reads were joined using fastq-join22 with a minimum 200 bp overlap and 5% 197 
maximum difference, de-multiplexed, and quality filtered using a Phred threshold of >20. 198 
Sequences were clustered into operational taxonomic units (OTUs) at 97% similarity with 199 
uclust23 using an open reference scheme against the Greengenes database, 24 where non-matching 200 
reads were retained and clustered de novo. Sequences were aligned with PyNAST25 and the 201 
phylogenetic tree used for downstream analysis was generated using FastTree.26 Samples were 202 
normalized for sequencing depth by rarefaction at 15,958 reads, and one sample (Simulation II, 203 
Time 48, 2% PDX 13C, vessel 1) was removed due to low coverage. α-diversity was assessed by 204 
the phylogenic diversity whole tree metric27 and compared between groups using non-parametric 205 
t-tests with 999 Monte Carlo permutations. β-diversity was measured using the weighted 206 
UniFrac distance 28 and groups were compared with Analysis of Similarities (ANOSIM). Genera 207 
(or higher taxonomic levels if the genus could not be confirmed) comprising >0.2% abundance 208 
were compared between groups using Kruskal-Wallis tests and graphed using Prism 7 (GraphPad 209 
Software, La Jolla, California, USA). P values were adjusted for multiple comparisons with the 210 
Benjamini-Hochberg false discovery rate (FDR) correction and p<0.05 was considered a 211 
significant difference for all tests.   212 
  213 
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Results and Discussion 214 
This work focused on the study of [U-13C] labelled PDX as a substrate during microbial 215 
digestion and characterization of 13C-labelled metabolites in different compartments of an in 216 
vitro colon simulator. The 13C-labelled metabolites were characterized by liquid-state and solid-217 
state NMR spectroscopy. GC-MS was performed to evaluate the gas generated during [U-13C] 218 
PDX catabolism. In addition, 16S rRNA gene sequencing was performed to study the phylogeny 219 
and taxonomy of the gut microbiome from the in vitro gut fermentation.    220 
  221 
Solution state analysis 222 
A significant effect of [U-13C] PDX metabolism was observed in 13C NMR spectra obtained 223 
from colonic digest extracts. When compared to experiments using a natural abundance 224 
reference PDX reference, the spectra with [U-13C] PDX clearly show the low-molecular-weight 225 
compounds generated from carbohydrate metabolism (Figure 1B). The results show that the 226 
major 13C-labelled metabolites included acetate, butyrate, propionate, and valerate. To map these 227 
metabolic changes, peak integrals were obtained from 13C NMR spectra and plotted accordingly 228 
(SI, Figure S1). Even though an inter-individual variation is apparent, the integrals indicate that 229 
the SCFA concentrations gradually increased from the ascending colon (V1) to the descending 230 
colon (V3) during the simulation. The overall metabolite concentration decreased in the sigmoid 231 
colon part (V4) during 24 hours while it remained stable at 48 hours (SI, Figures S1-S4).  232 
Intriguingly, the pattern seen in SCFA formation is supported by the degradation pattern of PDX 233 
as the concentration of PDX decreased during simulation from the proximal colon to the sigmoid 234 
colon at 48 hours (SI, Figure S3), however, an inter-individual difference between the donors 235 
exists mainly at 24 hours. Thus, our result reveal how fiber/substrate availability affects the gut 236 
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fermentation pattern and SCFA concentrations in different segments of the gut over time. The 237 
present study corroborates that PDX fiber fermentation results in the synthesis of SCFAs as 238 
eminent metabolic end products.29 Previous reports from animal models, in vitro models, and 239 
humans have shown increased fecal levels of butyrate and acetate in subjects after PDX intake.16, 240 
30-31 However, none of these studies measured the microbial metabolites derived directly from 241 
PDX catabolism. We report a novel approach to determine the specific metabolites generated 242 
from PDX fermentation. Furthermore, this in vitro study enabled us to directly monitor the 243 
dynamics of microbial metabolites formed during PDX fermentation in different parts of the 244 
colon at different time point (24 hrs and 48 hrs), while the same information would be practically 245 
and ethically impossible to obtain in vivo in humans.  The result revealed that acetate clearly is 246 
the principal SCFA produced, however butyrate is of particular interest as it has been described 247 
as a vital metabolite for colon.32-33 An increase in SCFA production, specifically butyrate 248 
formation in the colon simulator, can be considered as the primary metabolic significance of 249 
PDX digestion in relation to gut microbial activity and benefits for host. Interestingly, our data 250 
also revealed an increased level of valerate from V1 to V4 due to PDX catabolism (for inoculum 251 
from subject). Until now, studies focussing on valerate as product of carbohydrate metabolism 252 
have been sparse.34-36 Although only observed in one subject, our finding indicates a possible 253 
direct association between dietary fiber fermentation, valerate formation, and gut microbial 254 
activity. However, to validate this hypothesis, other independent studies are needed. 255 
 256 
In addition to SCFAs, we identified 13C labelled lactate, formate, succinate, and ethanol in the 257 
fecal 13C NMR spectra. As the colon simulator genuinely allowed dynamic sampling, we 258 
comprehensively examined these biochemical changes over time (24 and 48 hours) in the vessels 259 
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(SI, Figures S1-S4). The results show that succinate, lactate, and formate mainly appeared in 260 
vessel V1 and V2 (ascending and transverse colon) during the fermentation, but an inter-261 
individual difference between the donors was observed. This inter-individual variation can be 262 
ascribed to the differential microbial composition between individuals and the result suggests 263 
that these metabolites are metabolised further and thus disappear in V3 and V4 (described 264 
below). A previous study has shown that lactate can be fermented to SCFAs (mainly butyrate) by 265 
human intestinal bacteria.37 Previous work also supports the finding that lactate accumulates at 266 
low pH (pH 5.2 likewise in V1 colon simulation) but butyrate and propionate production were 267 
initiated at pH 5.9 and 6.4, respectively, equivalent to the pH of descending and sigmoid colon 268 
(V3 and V4) in the simulation.38 269 
 Similarly, formate is involved in acetate formation via the Wood-Liungdhal pathway and 270 
succinate is a well-known precursor for the formation of propionate through the succinate 271 
pathway (Figure 2).29 Interestingly, studies have also shown that when sufficient carbohydrate is 272 
present during bacterial metabolism, succinate is accumulated due to a reduced requirement for 273 
succinate decarboxylation.39 Figure 2 depicts the possible pathways linked to carbohydrate 274 
(PDX) catabolism and metabolites formation in the gut during the anaerobic microbial process. 275 
Accumulation of lactate, formate, and succinate (V1 and V2) indicates an imbalance between the 276 
production and consumption pathway involved in anaerobic gut metabolism. However, the 277 
finding also reflects diverse microbiota composition/activity and potential cross feeding between 278 
microbes in the gut simulator.  279 
 280 
The structure of the randomly formed PDX is rather complex and is composed of both linear and 281 
branched α and β- 1-2, 1-3, 1-4 and 1-6 linkages, dominated by 1-6.40-41 The 13C spectra 282 
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indicated the presence of partly undigested 13C-labelled PDX especially in vessels V1 and V2 283 
alongside metabolic intermediates, while sharper carbohydrate signals emerge especially in 284 
vessels V3 and V4. The degradation pattern of residual PDX suggests that vessels V1 and V2 285 
(ascending to transverse colon) had similar metabolic patterns, as did vessels V3 and V4 286 
(descending to sigmoid colon), respectively (Figure 3). In particular, the results indicate that 287 
vessels V1 and V2 had residual polysaccharide with broadened signals near 111.5 ppm (β-288 
glucofuranosyl), 106 ppm (predominantly β-gluco-pyranosyl), 104 ppm (levoglucosan (β-1,6 289 
anhydroglucose) and 101 ppm (α-gluco-pyranosyl). Increasingly sharper signals in these regions 290 
emerged in vessels V1 to V4 due to polysaccharide degradation to smaller units, which could be 291 
ascribed to enzymatic or acid hydrolysis. The glucofuranosyl units are increasingly represented 292 
in vessels 3 and 4, possibly due to a lack of efficient enzymes degrading glucofuranosyl linkages. 293 
The results show that free glucose also varies in different compartments of the colon simulator.42-294 
43 Our finding is in agreement with a former study where it was reported that glucofuranosyl 295 
moiety is accumulated in the final vessel indicating a lesser ability of the microbiota to degrade 296 
the glucofuranosyl structure.41  297 
 298 
Solid-state analysis   299 
The residual pellets obtained from the microbial slurry were examined using CP MAS NMR 300 
spectroscopy. Figure 4A shows representative 13C CP MAS spectra obtained from the pellet of 301 
the anaerobic microbial degradation of PDX during simulation. To our knowledge, this paper 302 
presents the first work examining the triple phases in fecal samples (in vitro simulation), in 303 
particular CP MAS from the fecal slurry (in vitro samples) has not been reported before. The CP 304 
MAS spectra showed characteristic peaks that can be assigned to the carbohydrate, carbonyl, 305 
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CH2, CH3, anomeric and aromatic resonances.
44 The 13C MAS NMR spectrum is a sum of [U-306 
13C] PDX, 13C metabolites, and natural abundance (1%) of 13C from major undigested 307 
components such as cellulose, ligno-cellulose, undigested protein and fat, and bacterial cell 308 
debris. Thus, collectively data provide valuable information about the heterogeneity of microbial 309 
activity from proximal to distal section of the gut. As shown in the score plot depicted in Figure 310 
4B, overall the intensity of signals from carbohydrate and anomeric resonances were decreased 311 
from vessel V1 to V4 while carbonyl, CH2, CH3 resonances were higher in V1 to V3 (ascending 312 
to descending colon) and did not noticeably change in V4 (sigmoid colon) indicating that 313 
substrate availability affects the gut fermentation pattern. This information is unique and adds to 314 
the finding obtained from solution-state NMR. 315 
 316 
Gas-state analysis 317 
In general, CO2 and CH4 are the products of carbohydrate fermentation during anaerobic 318 
microbial metabolism. We detected 12CO2 (m/z 44) and 
13CO2 (m/z 45), while CH4 was not 319 
detected. This finding may be explained by the fact that CH4 is produced only in 30 % -50 % of 320 
healthy adults.45 As expected, the ratio 13CO2/
12CO2 shows a marked difference between the 321 
fecal extract with [U-13C] PDX or a natural abundance PDX reference (Figure 5). In addition, the 322 
heat map (Figure 6) depicts positive correlations between 13CO2/
12CO2 ratio and intensity of 323 
SCFA signals in the liquid-state 13C NMR spectra. In addition, the 13CO2/
12CO2 ratio shows 324 
negative correlation to certain regions of the PDX signals in 13C NMR spectra. GC-MS results 325 
are thus consistent with NMR analyses and provide an additional angle to [U-13C] PDX 326 
catabolism and microbial metabolism in the gut simulator.  327 
 328 
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Microbiome analysis 329 
To measure the in vitro colonic microbial composition, α-diversity and β-diversity were 330 
compared between the groups. The α-diversity measures the OTU diversity within the samples 331 
whereas β-diversity measures dissimilarity between each sample pairing at the OTU level. The 332 
results showed that α-diversity was only significantly different between simulations performed 333 
with inoculum obtained from the donors I/II and I/III (Figure 7A, p = 0.006). These groups were 334 
compared with a non-parametric t-test using 999 Monte Carlo permutations and the p-value was 335 
adjusted using the Benjamini-Hochberg FDR. However, the α-diversity from other 336 
simulation/treatment and simulation/time comparisons did not show any significant differences. 337 
In contrast, the results depicted that β-diversity was significantly different between simulation 338 
times (24 hours and 48 hours) and simulations performed from different donors I, II and III 339 
(Figure 7B). The principal coordinate analysis (PCoA) for the weighted UniFrac distance matrix 340 
showed significant differences between the simulation from three donors (p=0.001) and to a 341 
lesser degree simulation time (p=0.01), whereas the treatment effect was insignificant 342 
(p=0.1029).   343 
An analysis of genera and higher-level taxonomy between different categories showed few 344 
bacterial lineages shifted in relative abundances after the PDX supplementation, with increasing 345 
levels of Erysipelotrichaceae being most pronounced. The Erysipelotrichaceae family was found 346 
to be significantly different in control and treatment for all simulations (Figure 8). In addition, 347 
the PDX resulted in an increased level of Bifidobacterium and in a decreased level of 348 
Lactobacillus, but these changes were not as prominent as Erysipelotrichaceae. Recently, 349 
Erysipelotrichaceae has gained substantial attention in gut microbial research due to its potential 350 
role in host physiology and/or disease conditions.46-48 Evidence support an association 351 
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between Erysipelotrichaceae and metabolic disorders47 and inflammation-related disorders of the 352 
gastrointestinal tract.48-49 In addition, studies have shown that diet influences the relative 353 
abundance of Erysipelotrichaceae family in the gut.47, 50-52 Previous studies have shown positive 354 
correlations between Erysipelotrichaceae occurrence and complex carbohydrate consumption.51-355 
52 The Erysipelotrichaceae family is designated as SCFA producers, and some species within 356 
this family are capable of producing butyrate.53-54 Meanwhile, other studies have shown this 357 
bacterial family to be enhanced from high-fat diets.55-56 This is not unexpected, as identical gut 358 
microbial genera can have both specific and shared systemic effects.57-58 Moreover, our results 359 
substantiate an enrichment of Erysipelotrichaceae family during complex carbohydrate (PDX) 360 
fermentation. Specifically, our results suggest that associations between PDX fermentation, 361 
Erysipelotrichaceae and SCFA production exist (supported by correlation analysis, heat map 362 
Figure 9), albeit using a limited set of donors. Independent studies with larger samples sets are 363 
required to disclose a possible link, and further analysis at strain levels within 364 
Erysipelotrichaceae may expand our current knowledge.59   365 
 366 
13
C incorporation and statistical correlation between metabolites and microbiome 367 
 LC-MS analysis enabled us to determine the level of isotope incorporation in the SCFAs during 368 
in vitro colon simulation. The results indicate that there was clear difference in the 13C isotope 369 
incorporation among different subjects and vessels over time. In particular, butyrate showed high 370 
variability when compared to acetate and propionate (SI, Figures S5-S8). Meanwhile, these data 371 
provide an opportunity to explore if any statistical relation between metabolites and microbes in 372 
the colon simulator exists at isotope level. The correlation analysis (Figure 9) between OTUs 373 
(included OUT with zero values reported in ≤ 1 sample) and integrals of the metabolites (m/z 374 
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from LC-MS analysis) suggests an statistical association between bacterial family 375 
Erysipelotrichaceae, Faecalibacterium and SCFAs. The correlation was found to be significant 376 
with Erysipelotrichaceae (p value < 0.05) for most of the 13C isotopes from SCFAs. Intriguingly, 377 
we did also see that Erysipelotrichaceae  were increased in PDX treated samples. In fact our 378 
finding, is also in agreement with previous findings relating Erysipelotrichaceae and 379 
Faecalibacterium family to SCFA producers.53-54 In addition, Blautia was positively correlated 380 
to butyrate. The statistical correlation indicates that both of these bacterial family may be 381 
actively involved in the PDX fermentation and butyrate formation in the colon simulator. In fact, 382 
previous studies have reported Blautia  and Clostridiales to be a common bacterial genus in the 383 
human gut belonging to a butyrate-producing bacterial species.60-61 However, we saw negative 384 
correlation between Clostridiales and butyrate. The discrepency might be linked to higher 385 
abudance of  Erysipelotrichaceae which  possibly dominated the butyrate production in the in-386 
vitro colon.  387 
 388 
Likewise, 13C incorporation of propionate was positively correlated to Parabacteroides and 389 
Bacteroidetes. The phylum Bacteroidetes has been reported to be major propionate produce, 390 
even though it could also produce acetate and butyrate.62-63  Furthermore, we saw negative 391 
correlation between Bifidobacterium and 13C labelled butyrate (Figure 9). Bifidobacterium are 392 
well known carbohydrate degraders but they are antioxidants, polyphenols, and  conjugated 393 
linoleic acids producers.64-65 The negative association seen here may be indication of cross 394 
feeding interactions between Bifidobacterium and butyrate-producing colon bacteria.66 However, 395 
the underlying relation is not yet clear. These findings may be corroborated from future studies 396 
using more donors. Taken together, our findings substantiate the association of various microbes 397 
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with fermented gut microbial products. Here, we provide a novel methodological approach to 398 
study gut microbial function using stable isotope tracking. This approach could enable in-depth 399 
functional microbial analyses by directly linking substrate fermentation and microbial function in 400 
the gut system.  401 
Conclusion 402 
Overall, the present study showed that the application of a triple-phase study (solid, liquid, and 403 
gas) combined with 13C labelling monitors the overall and specific metabolites derived directly 404 
from in vitro colonic PDX catabolism. The correlation between 13C NMR spectra and 13C CO2 405 
production substantiates the anaerobic fermentation of PDX to SCFAs. Furthermore, the 16S 406 
rRNA gene analysis depicted that Erysipelotrichaceae, a butyrate-producing bacterial lineage 407 
changed in relative abundance after the PDX supplementation in the in vitro colon simulator. 408 
Further, statistical correlation analysis showed that Erysipelotrichaceae and Blautia is positively 409 
correlated to 13C SCFAs while the Parabacteroides is linked to 13C propionate formation from 410 
PDX metabolism in an in vitro colon simulator. Overall, the study proposes a novel approach to 411 
link substrate fermentation and microbial function directly in a simulated gut system.  412 
 413 
ASSOCIATE CONTENT 414 
SUPPORTING INFORMATION 415 
The following associated information is available free of charge on ACS publications website 416 
Supplementary methods on 1H NMR experiments. 417 
Figure S1-S4: Integrals of 13C labelled acetate, 13C labelled butyrate, 13C labelled propionate, 13C 418 
labelled succinate, 13C PDX region 1 (104.5-103.9ppm), 13C labelled lactate, 13C valerate and 13C 419 
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labelled formate obtained from each vessel (V1 to V4) representing different areas of the colon 420 
i.e. proximal to the distal part in the colon simulator.   421 
Figure S5 showing the representative MS spectra showing the m/z ratio for acetate, propionate 422 
and butyrate. Figure S6-S8 illustrating the 13C incorporation at isotopic level in the butyrate, 423 
acetate and propionate for three donors at 24 and 48 hours. 424 
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Figure Captions 444 
Figure 1. The in vitro colon simulator and representative 13C NMR spectra obtained from the 445 
colon simulation. A) Schematic depiction of the in vitro colon simulator. Each vessel (V1–V4) in 446 
colon simulator models the different compartments of the human colon from ascending (V1), 447 
transverse (V2), descending (V3) and sigmoidal (V4) parts, each having a different pH and flow 448 
rate.  B) Representative 13C NMR spectrum from the simulated faecal sample with [U-13C] 449 
labelled PDX. Here, acetate (A), butyrate (B), propionate (P), and valerate (V) were the main 450 
metabolites produced during in vitro fermentation.  C) Representative 13C NMR spectrum of the 451 
simulated faecal sample with non-labelled PDX. D) The NMR spectra obtained from the control 452 
sample without PDX.   453 
Figure 2. Schematic illustration of compounds produced from [U-13C] PDX catabolism. The 454 
compound illustrated with dark green stars ( ) are the major products of fermentation, while 455 
light green stars ( ) show the intermediates or the less abundant metabolites in the NMR spectra. 456 
The red stars ( ) represent the gaseous metabolites detected by GC-MS. 457 
Figure 3. The 60-110 ppm region in representative 13C NMR spectra. Black spectra represent 458 
different vessels in the colon simulator while the red spectrum represents a spectrum obtained 459 
from pure and undigested substrate. The sharp signal at 104 ppm in PDX (black star) is 460 
tentatively assigned to levoglucosan, which is a common by product of PDX formation (through 461 
acid-catalysed dehydration). The signal at 107 ppm (green star) most likely is in the same 462 
molecule as those at 83, 82, 80.5, 69 and 66 ppm (chemical shifts of a furanose-form). The broad 463 
signals at 106-ppm (red star) and 101 ppm (see for instance PDX substrate spectrum) are 464 
assigned to β-glucopyranosyl and α-glucopyranosyl units, respectively. 465 
Figure 4. 
13CP MAS NMR of simulated fecal pellets. A) Representative 13CP MAS NMR 466 
spectrum of simulated fecal pellets. B) PCA score plot and C) Loading plot. The PCA score and 467 
loading plot reflects the time/vessels dependent changes in the direction of PC3. The signals 468 
from carbohydrate and anomeric resonances decreased from V1 to V4 while carbonyl, CH2, CH3 469 
resonances increased from V1 to V2. 470 
Figure 5. 
13CO2/
12CO2 ratio as determined with GC-MS. The representative plot shows the ratio 471 
for a simulation obtained from a single donor.  472 
Figure 6. Correlation coefficients illustrated by heat map. The Pearson correlation coefficient 473 
(R) value revealed positive correlation between 13CO2 /12CO2 ratio and integrals of SCFA 474 
signals. Meanwhile the 13CO2 /12CO2 ratio shows negative correlation to certain region of PDX 475 
signals in 13C NMR spectra (PDX1 (104.5-103.9ppm) PDX2 (106.9 – 106.5 ppm) PDX3 (80.8 – 476 
80.5 ppm) PDX4 (69.4-69.2 ppm)). The color-coding in the figure represents the R-values. 477 
(× indicates significant correlation p values < 0.05).      478 
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Figure 7. Microbial diversity between the three simulations. A) Boxplots show overall α-479 
diversity (diversity within samples) in each simulation using the PD whole tree metric. Groups 480 
were compared with a non-parametric t-test using 999 Monte Carlo permutations and the p-value 481 
was adjusted using the Benjamini-Hochberg FDR method. Significantly different p values are 482 
denoted. B) The β-diversity (diversity between samples) of each simulation is visualized by 483 
principal coordinate analysis by weighted UniFrac distance matrix. Colors denote the different 484 
simulation numbers: red squares, I; blue circles, II, orange triangles, III. The results were 485 
obtained using the ANOSIM statistical method. 486 
Figure 8. Relative abundances of 16S rDNA in all samples at the genus, family (f) or order (o) 487 
levels. Samples are ordered by simulation number, simulation time, and the various treatment 488 
types: I (inoculum), CTRL (control, without PDX), PDX (2% PDX) and [U-13C] PDX (13C 2% 489 
PDX). The 35 most abundant taxa are shown, with “all other” signifying all other organisms that 490 
are <0.2% average abundance. Significant differences are denoted by asterisk (* p<0.05) in order 491 
of treatment (CTRL: PDX, CTRL: [U-13C] PDX), and by simulation number (I/II/ III) following 492 
taxa names. 493 
Figure 9. The spearman correlation coefficient (R). The value illustrated by heat map indicate 494 
blue is positive correlation while the red gradient indicates negative correlation (× indicates 495 
significant correlation, p values < 0.05).  ). Here, N represents the natural abundance of given 496 
metabolites and the label +1, +2, +3, +4 represents the shifts of the mass of the given metabolite 497 
by one, two, three or four units due to 13C label, respectively. 498 
 499 
 500 
  501 
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